Masami Inoue

Summary

Affiliation: The University of Tokyo
Country: Japan

Publications

  1. doi request reprint The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study
    Daisuke Hasegawa
    Department of Pediatrics, St Luke s International Hospital, Tokyo, Japan
    Pediatr Blood Cancer 58:23-30. 2012
  2. doi request reprint Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99)
    Daisuke Hasegawa
    Department of Pediatrics, St Luke s International Hospital, Tokyo, Japan
    Pediatr Blood Cancer 53:1011-5. 2009
  3. doi request reprint Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children
    Hiroshi Yagasaki
    Department of Pediatrics, School of Medicine, Nihon University, 30 1 Ohyaguchi Kamicho, Itabashi ku, 173 8610, Tokyo, Japan
    Ann Hematol 93:747-52. 2014
  4. doi request reprint Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 16:231-8. 2010
  5. doi request reprint Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Pediatr Blood Cancer 61:925-7. 2014
  6. doi request reprint PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor
    Aki Shinzato
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Pediatr Blood Cancer 60:1513-9. 2013
  7. doi request reprint Clinicopathological characteristics of erythroblast-rich RAEB and AML M6a in children
    Yuko Honda
    Department of Pediatrics, University of Occupational and Environmental Health, Kitakyusyu, Japan
    Int J Hematol 88:524-9. 2008
  8. doi request reprint Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan
    Shouichi Ohga
    Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Pediatr Blood Cancer 54:299-306. 2010
  9. doi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan
    Emiko Sato
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi, Osaka, Japan
    Am J Hematol 83:721-7. 2008
  10. doi request reprint Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents
    Hiroyuki Ishida
    Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan Division of Pediatrics, Matsushita Memorial Hospital, Moriguchi, Japan
    Pediatr Blood Cancer 62:883-9. 2015

Collaborators

Detail Information

Publications18

  1. doi request reprint The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study
    Daisuke Hasegawa
    Department of Pediatrics, St Luke s International Hospital, Tokyo, Japan
    Pediatr Blood Cancer 58:23-30. 2012
    ..Based on the results from our previous study, we deferred the initial lumbar puncture until day 8 in remission induction therapy in order to reduce the frequency of cases with TLP+...
  2. doi request reprint Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99)
    Daisuke Hasegawa
    Department of Pediatrics, St Luke s International Hospital, Tokyo, Japan
    Pediatr Blood Cancer 53:1011-5. 2009
    ..Several reports have shown the efficacy of immunosuppressive therapy (IST) in adult patients with refractory anemia (RA), but its safety and efficacy remains to be fully elucidated in childhood RA...
  3. doi request reprint Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children
    Hiroshi Yagasaki
    Department of Pediatrics, School of Medicine, Nihon University, 30 1 Ohyaguchi Kamicho, Itabashi ku, 173 8610, Tokyo, Japan
    Ann Hematol 93:747-52. 2014
    ..5, 95.8, and 96.8 %). These findings indicate that IST with ATG and CsA is justified as a first-line treatment for children with FAA who lack a human leukocyte antigen-matched sibling donor. ..
  4. doi request reprint Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Biol Blood Marrow Transplant 16:231-8. 2010
    ..These findings provide important information for assessing the indications for and improving outcome in unrelated BMT for the treatment of pediatric CML...
  5. doi request reprint Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome
    Hideki Muramatsu
    Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Pediatr Blood Cancer 61:925-7. 2014
    ..0% (20.4-96.9%) vs. 10.0% (0.6%-35.8%), p = 0.039)...
  6. doi request reprint PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor
    Aki Shinzato
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Pediatr Blood Cancer 60:1513-9. 2013
    ..Since peripheral blood stem cell bank from unrelated volunteer donor has been started in Japan, use of PBSC allografts may be increased. Therefore we surveyed the outcomes of Japanese leukemia children after PBSC and BM transplantation...
  7. doi request reprint Clinicopathological characteristics of erythroblast-rich RAEB and AML M6a in children
    Yuko Honda
    Department of Pediatrics, University of Occupational and Environmental Health, Kitakyusyu, Japan
    Int J Hematol 88:524-9. 2008
    ..Five with group A and seven with group B undergoing SCT are alive at a median of 3 years after diagnosis. Erythroblast-rich RAEB and AML M6a in children have similar characteristics and may belong to a single disease entity...
  8. doi request reprint Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan
    Shouichi Ohga
    Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
    Pediatr Blood Cancer 54:299-306. 2010
    ..Post-transplant outcomes of hemophagocytic lymphohistiocytosis (HLH) patients were analyzed in Japan where Epstein-Barr virus (EBV)-associated severe forms are problematic...
  9. doi request reprint Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan
    Emiko Sato
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, 840 Murodo cho, Izumi, Osaka, Japan
    Am J Hematol 83:721-7. 2008
    ..563 +/- 0.124. Thus, in a substantial number of cases, EBV-associated T/NK-LPD can be cured by either allogeneic conventional stem cell transplantation or reduced-intensity stem cell transplantation...
  10. doi request reprint Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents
    Hiroyuki Ishida
    Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan Division of Pediatrics, Matsushita Memorial Hospital, Moriguchi, Japan
    Pediatr Blood Cancer 62:883-9. 2015
    ....
  11. ncbi request reprint Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis
    Tomoko Kishimoto
    Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi City, Osaka, Japan
    Int J Hematol 78:453-6. 2003
    ..However, a greater number of patients and a longer observation period are needed before definitive conclusions can be drawn...
  12. doi request reprint Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation
    Makoto Yazaki
    Department of Pediatrics, Nagoya City East Medical Center, Nagoya, Aichi, Japan
    Biol Blood Marrow Transplant 15:439-46. 2009
    ..Early bacterial infection had a negative effect on survival for adults and the median day of development was 10 days after transplant, suggesting that the prevention of bacterial infection in the very early post-UCBT phase is important...
  13. doi request reprint Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation
    Motohiro Kato
    Department of Pediatrics, University of Tokyo, Tokyo, Japan
    Pediatr Blood Cancer 62:1844-50. 2015
    ..As a partner of total body irradiation (TBI) in hematopoietic stem cell transplantation (HSCT) for pediatric acute lymphoblastic leukemia (ALL), various cytotoxic agents are used, but the optimal combination is still unclear...
  14. doi request reprint Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis
    Hirokazu Kanegane
    Department of Pediatrics, Graduate School of Medicine, University of Toyama, Toyama, Japan
    Pediatr Allergy Immunol 23:488-93. 2012
    ..The prognosis of XLP is very poor, and hematopoietic stem cell transplantation (HSCT) is the only curative therapy. We characterized the clinical features and outcome of Japanese patients with XLP-1...
  15. doi request reprint Allogeneic hematopoietic stem cell transplantation for Chediak-Higashi syndrome
    Katsutsugu Umeda
    Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    Pediatr Transplant 20:271-5. 2016
    ..RIC-HSCT might be an alternative treatment for CHS similar to other types of HLH, at least for patients without active AP disease. ..
  16. pmc Pharmacokinetics and safety of voriconazole intravenous-to-oral switch regimens in immunocompromised Japanese pediatric patients
    Masaaki Mori
    Department of Pediatrics, Yokohama City University Medical Center, Yokohama, Japan
    Antimicrob Agents Chemother 59:1004-13. 2015
    ..This study has been registered at ClinicalTrials.gov under registration no. NCT01383993.)...
  17. ncbi request reprint Megatherapy with hematopoietic stem cell rescue as a preoperative treatment in unresectable pediatric malignancies
    Takaharu Oue
    Department of Pediatric Surgery, Department of Pediatrics, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
    J Pediatr Surg 38:130-3; discussion 130-3. 2003
    ..To elucidate the impact of preoperative MT on the treatments of pediatric advanced malignancies, the authors reviewed the timing of surgery, preoperative condition, postoperative recovery, and outcome...
  18. doi request reprint Detection of T lymphocytes with a second-site mutation in skin lesions of atypical X-linked severe combined immunodeficiency mimicking Omenn syndrome
    Taizo Wada
    Department of Pediatrics, Graduate School of Medical Science, Kanazawa University, Japan
    Blood 112:1872-5. 2008
    ..These findings suggest that the clinical spectrum of XSCID is quite broad and includes atypical cases mimicking Omenn syndrome, and highlight the importance of revertant mosaicism as a possible cause for variable phenotypic expression...